Advertisement
Advertisement

VOR

VOR logo

Vor Biopharma Inc. Common Stock

13.03
USD
Sponsored
-0.96
-6.87%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

12.99

-0.04
-0.30%

VOR Earnings Reports

Positive Surprise Ratio

VOR beat 8 of 20 last estimates.

40%

Next Report

Date of Next Report
Mar 18, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.65
Implied change from Q3 25 (Revenue/ EPS)
--
/
-50.45%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-81.25%

Vor Biopharma Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, VOR reported earnings of -3.33 USD per share (EPS) for Q3 25, missing the estimate of -3.28 USD, resulting in a -1.39% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.67% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -1.65 USD, with revenue projected to reach -- USD, implying an decrease of -50.45% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Vor Biopharma Inc. Common Stock reported EPS of -$3.33, missing estimates by -1.39%, and revenue of $0.00, 0% as expectations.
The stock price moved up 2.67%, changed from $9.75 before the earnings release to $10.01 the day after.
The next earning report is scheduled for Mar 18, 2026.
Based on 7 analysts, Vor Biopharma Inc. Common Stock is expected to report EPS of -$1.65 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement